New scan could reveal brain tumor aggression without surgery
NCT ID NCT00850278
First seen Apr 21, 2026 · Last updated Jun 23, 2026 · Updated 6 times
Summary
This study tested a special PET scan tracer called FLT in 50 adults with brain tumors (gliomas or metastases). The goal was to see if FLT-PET can measure how fast tumor cells are growing, which could help doctors diagnose and predict tumor behavior better than current scans like MRI or MET-PET. Participants received FLT-PET, MET-PET, and MRI before surgery, and results were compared with lab tests and survival data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Caen University Hospital
Caen, 14033, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FLT (a radioactive tracer for PET imaging)
What this could lead to
If successful, FLT-PET could become a better way to see how aggressive a brain tumor is without surgery, helping doctors plan treatment more accurately.
What could go wrong
This is a small, early imaging study (50 people) that only looks at whether the scan works, not whether it improves outcomes. The tracer may not be better than existing methods.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.